ResearcherInsermActive in the last 2 years

Jean Lubrano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7163-0243; OpenAlex author ID A5112312713. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PROD… Co-author DOI 10.1200/jco-24-01378 ↗
Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after pancreaticoduodenectomy. Co-author DOI 10.1016/j.ejso.2018.03.024 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jean‐Robert Delpéro · 1 shared paper, 2018 · strength 0.08
- Paper Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after… DOI 10.1016/j.ejso.2018.03.024 ↗
Olivıer Turrini · 1 shared paper, 2018 · strength 0.08
- Paper Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after… DOI 10.1016/j.ejso.2018.03.024 ↗
François Paye · 1 shared paper, 2018 · strength 0.08
- Paper Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after… DOI 10.1016/j.ejso.2018.03.024 ↗
António Sá Cunha · 1 shared paper, 2018 · strength 0.08
- Paper Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after… DOI 10.1016/j.ejso.2018.03.024 ↗
L. Chiche · 1 shared paper, 2018 · strength 0.08
- Paper Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after… DOI 10.1016/j.ejso.2018.03.024 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.